KWMG
PCRX icon

King Wealth Management Group’s Pacira BioSciences PCRX Stock Holding History

King Wealth Management Group’s Portfolio PCRX Stock Details PCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-8,000
Closed -$268K – 159
2020
Q1 		$268K Buy
+8,000
New +$332K 0.12% 105
2019
Q4 		– Sell
-9,000
Closed -$343K – 146
2019
Q3 		$343K Buy
+9,000
New +$359K 0.1% 89

Other funds holding PCRX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
SCM
Spyglass Capital Management San Francisco, California $1.41B AUM 7.96% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

King Wealth Management Group's PCRX Position: Q2 2020 in Review

King Wealth Management Group sold out of Pacira BioSciences (PCRX) in Q2 2020, closing a stake of 8,000 shares — an estimated $268K sold.

King Wealth Management Group first reported a position in PCRX in Q3 2019 and held it in 2 quarters. The position peaked at $343K in Q3 2019. 248 funds tracked by Wall St. Rank hold PCRX as of Q2 2020.

  • King Wealth Management Group reported no remaining Pacira BioSciences position as of Q2 2020 after selling out during the quarter.
  • King Wealth Management Group sold 8,000 Pacira BioSciences shares in Q2 2020, an estimated $268K.
  • King Wealth Management Group first reported a position in Pacira BioSciences in Q3 2019 and held it in 2 quarters.
  • King Wealth Management Group's Pacira BioSciences position peaked at $343K in Q3 2019.
  • 248 funds tracked by Wall St. Rank held Pacira BioSciences as of Q2 2020.

Based on King Wealth Management Group's 13F filing for Q2 2020, filed 13 Aug 2020.